While GDF11 was initially proposed as the major ligand of luspatercept, recent studies showing a lack of anemia improvement in the absence of GDF11 upon ineffective erythropoiesis suggest that other TGF‐β superfamily ligands are the functional targets of luspatercept. The gene discussed is GDF11; the disease is anemia.